Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Notable Labs, Ltd. (NTBLQ : OTC)

• Company Description    Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif. Number of Employees: 16

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 1 shares Shares Outstanding: 9.66 (millions) Market Capitalization: $0.00 (millions) Beta: 0.99 52 Week High: $0.81 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 320 HATCH DRIVE - FOSTER CITY,CA 94404 USA ph: 415-851-2410 fax: 972-8993-5001 daniel@lifesciadvisors.com http://www.notablelabs.com

• General Corporate Information    Officers Thomas Bock - Chief Executive Officer and Director Tuomo Patsi - Chairman Scott A. McPherson - Chief Financial Officer Peter Feinberg - Director Michele Galen - Director Peer Information Notable Labs, Ltd. (CORR.) Notable Labs, Ltd. (RSPI) Notable Labs, Ltd. (CGXP) Notable Labs, Ltd. (BGEN) Notable Labs, Ltd. (GTBP) Notable Labs, Ltd. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: M7517R107 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/24 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 9.66 Most Recent Split Date: 10.00 (0.03:1) Beta: 0.99 Market Capitalization: $0.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -57.30% vs. Previous Quarter: -30.95% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 100.00% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©